Search results
AACR: Synthekine hopes new IL-2 will be the high-alpha in a beta class
FierceBiotech· 1 week agoIL-2 medicines have shown the ability to kill tumors. Synthekine is hoping to avoid activating...
IL-2 medicines have shown the ability to kill tumors. Synthekine is hoping to avoid activating...